This led to the identification of the novel activity of reducing survivin levels in cancer cells for the known compounds eryloside E, ilicicolin H, tanzawaic acid A, and p-hydroxyphenopyrrozin whose structures are shown in Figure 1. This evidence concerns the gene BIRC5 and cancer.